Kwon J, Bakhoum SF. The cytosolic DNA-sensing cGAS-STING pathway in cancer. Cancer Discov. 2020;10(1):26–39.
Article PubMed CAS Google Scholar
Dvorkin S, Cambier S, Volkman HE, Stetson DB. New frontiers in the cGAS-STING intracellular DNA-sensing pathway. Immunity. 2024;57(4):718–30.
Article PubMed CAS Google Scholar
Coventry BJ, Henneberg M. The immune system and responses to cancer: coordinated. Evolution. 2015;4:552.
Whiteside TL. Tumor-infiltrating lymphocytes and their role in solid tumor progression. Exp Suppl. 2022;113:89–106.
PubMed PubMed Central CAS Google Scholar
Dinarello CA. Historical insights into cytokines. Eur J Immunol. 2007;37(Suppl 1):S34-45.
Article PubMed PubMed Central CAS Google Scholar
Hunter P. The fourth pillar: despite some setbacks in the clinic, immunotherapy has made notable progress toward becoming an additional therapeutic option against cancer. EMBO Rep. 2017;18(11):1889–92.
Article PubMed PubMed Central CAS Google Scholar
Zhou J, Ventura CJ, Fang RH, Zhang L. Nanodelivery of STING agonists against cancer and infectious diseases. Mol Aspects Med. 2022;83:101007.
Article PubMed CAS Google Scholar
Sun Y, Patterson-Fortin J, Han S, Li Z, Nowicka Z, Hirohashi Y, et al. 53BP1 loss elicits cGAS-STING-dependent antitumor immunity in ovarian and pancreatic cancer. Nat Commun. 2024;15(1):6676.
Article PubMed PubMed Central CAS Google Scholar
Hussain B, Xie Y, Jabeen U, Lu D, Yang B, Wu C, Shang G. Activation of STING based on its structural features. Front Immunol. 2022;13:808607.
Article PubMed PubMed Central CAS Google Scholar
Zhang ZD, Zhong B. Regulation and function of the cGAS-MITA/STING axis in health and disease. Cell Insight. 2022;1(1):100001.
Article PubMed PubMed Central Google Scholar
Zhao H, Wu L, Yan G, Chen Y, Zhou M, Wu Y, Li Y. Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther. 2021;6(1):263.
Article PubMed PubMed Central CAS Google Scholar
Tang W, Zhou W, Ji M, Yang X. Role of STING in the treatment of non-small cell lung cancer. Cell Commun Signal. 2024;22(1):202.
Article PubMed PubMed Central CAS Google Scholar
Zhang J, Yu S, Peng Q, Wang P, Fang L. Emerging mechanisms and implications of cGAS-STING signaling in cancer immunotherapy strategies. Cancer Biol Med. 2024;21(1):45–64.
PubMed PubMed Central CAS Google Scholar
Hines JB, Kacew AJ, Sweis RF. The development of STING agonists and emerging results as a cancer immunotherapy. Curr Oncol Rep. 2023;25(3):189–99.
Article PubMed PubMed Central Google Scholar
Barrueto L, Caminero F, Cash L, Makris C, Lamichhane P, Deshmukh RR. Resistance to checkpoint inhibition in cancer immunotherapy. Transl Oncol. 2020;13(3):100738.
Article PubMed PubMed Central Google Scholar
Jiang M, Chen P, Wang L, Li W, Chen B, Liu Y, et al. cGAS-STING, an important pathway in cancer immunotherapy. J Hematol Oncol. 2020;13(1):81.
Article PubMed PubMed Central CAS Google Scholar
Decout A, Katz JD, Venkatraman S, Ablasser A. The cGAS-STING pathway as a therapeutic target in inflammatory diseases. Nat Rev Immunol. 2021;21(9):548–69.
Article PubMed PubMed Central CAS Google Scholar
Paludan SR, Pradeu T, Masters SL, Mogensen TH. Constitutive immune mechanisms: mediators of host defence and immune regulation. Nat Rev Immunol. 2021;21(3):137–50.
Article PubMed CAS Google Scholar
Li Y, Wilson HL, Kiss-Toth E. Regulating STING in health and disease. J Inflamm (Lond). 2017;14:11.
Yu L, Liu P. Cytosolic DNA sensing by cGAS: regulation, function, and human diseases. Signal Transduct Target Ther. 2021;6(1):170.
Article PubMed PubMed Central CAS Google Scholar
Wheeler OPG, Unterholzner L. DNA sensing in cancer: pro-tumour and anti-tumour functions of cGAS-STING signalling. Essays Biochem. 2023;67(6):905–18.
Article PubMed PubMed Central CAS Google Scholar
Herzner AM, Hagmann CA, Goldeck M, Wolter S, Kubler K, Wittmann S, et al. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nat Immunol. 2015;16(10):1025–33.
Article PubMed PubMed Central CAS Google Scholar
Pan J, Fei CJ, Hu Y, Wu XY, Nie L, Chen J. Current understanding of the cGAS-STING signaling pathway: structure, regulatory mechanisms, and related diseases. Zool Res. 2023;44(1):183–218.
Article PubMed PubMed Central CAS Google Scholar
Mosallanejad K, Kagan JC. Control of innate immunity by the cGAS-STING pathway. Immunol Cell Biol. 2022;100(6):409–23.
Article PubMed PubMed Central CAS Google Scholar
Barral PM, Sarkar D, Su ZZ, Barber GN, DeSalle R, Racaniello VR, Fisher PB. Functions of the cytoplasmic RNA sensors RIG-I and MDA-5: key regulators of innate immunity. Pharmacol Ther. 2009;124(2):219–34.
Article PubMed PubMed Central CAS Google Scholar
Brisse M, Ly H. Comparative structure and function analysis of the RIG-I-like receptors: RIG-I and MDA5. Front Immunol. 2019;10:1586.
Article PubMed PubMed Central CAS Google Scholar
Balka KR, Louis C, Saunders TL, Smith AM, Calleja DJ, D’Silva DB, et al. TBK1 and IKKepsilon act redundantly to mediate STING-induced NF-kappaB responses in myeloid cells. Cell Rep. 2020;31(1):107492.
Article PubMed CAS Google Scholar
Yang J, Ding H, Shuai B, Zhang Y, Zhang Y. Mechanism and effects of STING-IFN-I pathway on nociception: a narrative review. Front Mol Neurosci. 2022;15:1081288.
Article PubMed CAS Google Scholar
Srikanth S, Woo JS, Wu B, El-Sherbiny YM, Leung J, Chupradit K, et al. The Ca(2+) sensor STIM1 regulates the type I interferon response by retaining the signaling adaptor STING at the endoplasmic reticulum. Nat Immunol. 2019;20(2):152–62.
Article PubMed PubMed Central CAS Google Scholar
Uhlorn BL, Gamez ER, Li S, Campos SK. Attenuation of cGAS/STING activity during mitosis. Life Sci Alliance. 2020;3(9):e201900.
B
Comments (0)